» Articles » PMID: 33034351

Enhancer RNA: Biogenesis, Function, and Regulation

Overview
Journal Essays Biochem
Specialty Biochemistry
Date 2020 Oct 9
PMID 33034351
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Enhancers are noncoding DNA elements that are present upstream or downstream of a gene to control its spatial and temporal expression. Specific histone modifications, such as monomethylation on histone H3 lysine 4 (H3K4me1) and H3K27ac, have been widely used to assign enhancer regions in mammalian genomes. In recent years, emerging evidence suggests that active enhancers are bidirectionally transcribed to produce enhancer RNAs (eRNAs). This finding not only adds a new reliable feature to define enhancers but also raises a fundamental question of how eRNAs function to activate transcription. Although some believe that eRNAs are merely transcriptional byproducts, many studies have demonstrated that eRNAs execute crucial tasks in regulating chromatin conformation and transcription activation. In this review, we summarize the current understanding of eRNAs from their biogenesis, functions, and regulation to their pathological significance. Additionally, we discuss the challenges and possible mechanisms of eRNAs in regulated transcription.

Citing Articles

The RNA Revolution in the Central Molecular Biology Dogma Evolution.

Haseltine W, Patarca R Int J Mol Sci. 2024; 25(23).

PMID: 39684407 PMC: 11641533. DOI: 10.3390/ijms252312695.


Revisiting Epigenetics Fundamentals and Its Biomedical Implications.

Meza-Menchaca T, Albores-Medina A, Heredia-Mendez A, Ruiz-May E, Ricano-Rodriguez J, Gallegos-Garcia V Int J Mol Sci. 2024; 25(14).

PMID: 39063168 PMC: 11276703. DOI: 10.3390/ijms25147927.


Exploring the enigma: history, present, and future of long non-coding RNAs in cancer.

Naseer Q, Malik A, Zhang F, Chen S Discov Oncol. 2024; 15(1):214.

PMID: 38847897 PMC: 11161455. DOI: 10.1007/s12672-024-01077-y.


LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1.

Liu D, Wang W, Wu Y, Qiu Y, Zhang L Curr Cancer Drug Targets. 2024; 24(5):519-533.

PMID: 38804344 DOI: 10.2174/0115680096258716231026063704.


CCAT1 lncRNA is chromatin-retained and post-transcriptionally spliced.

Bohrer C, Varon E, Peretz E, Reinitz G, Kinor N, Halle D Histochem Cell Biol. 2024; 162(1-2):91-107.

PMID: 38763947 PMC: 11227459. DOI: 10.1007/s00418-024-02294-w.